PharmaCyte Biotech, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
PharmaCyte Biotech, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • PharmaCyte Biotech, Inc. Return On Equity for the quarter ending July 31, 2024 was 75.1 %.
  • PharmaCyte Biotech, Inc. annual Return On Equity for 2023 was 0.42 %.
  • PharmaCyte Biotech, Inc. annual Return On Equity for 2022 was -6.19 %, a 89.5% increase from 2021.
  • PharmaCyte Biotech, Inc. annual Return On Equity for 2021 was -58.9 %, a 21.5% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 0.42 +6.61 May 1, 2023 Apr 30, 2024
2022 -6.19 +52.7 +89.5% May 1, 2022 Apr 30, 2023
2021 -58.9 +16.1 +21.5% May 1, 2021 Apr 30, 2022
2020 -75 -5.44 -7.82% May 1, 2020 Apr 30, 2021
2019 -69.6 -10.6 -18.1% May 1, 2019 Apr 30, 2020
2018 -58.9 +37 +38.6% May 1, 2018 Apr 30, 2019
2017 -95.9 -32.9 -52.1% May 1, 2017 Apr 30, 2018
2016 -63.1 +22.8 +26.6% May 1, 2016 Apr 30, 2017
2015 -85.9 +116 +57.5% May 1, 2015 Apr 30, 2016
2014 -202 -1.57K -115% May 1, 2014 Apr 30, 2015
2013 1.37K +1.3K +1895% May 1, 2013 Apr 30, 2014
2012 68.7 May 1, 2012 Apr 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.